IXC-S Etoricoxib & Serratiopeptidase Tablets

IXC-T4
IXC-T4 Etoricoxib & Thiocolchicoside Tablets
July 11, 2025
LETROGO 2.5
LETROGO 2.5 Letrozole Tablets IP
July 11, 2025
IXC-S

IXC-S Etoricoxib & Serratiopeptidase Tablets are a combination medication formulated to provide effective relief from pain, swelling, and inflammation associated with a variety of musculoskeletal and inflammatory conditions.

Product Description:
1. Composition: Each tablet contains a combination of Etoricoxib (a selective COX-2 inhibitor, classified as a non-steroidal anti-inflammatory drug or NSAID) and Serratiopeptidase (a proteolytic enzyme).

2. Indications: This medication is used for the management of:
Osteoarthritis and rheumatoid arthritis
Ankylosing spondylitis
Low back pain and cervical pain
Post-traumatic pain and sports injuries
Dental pain and swelling
Postoperative pain and tissue inflammation

3. Mechanism of Action:
Etoricoxib works by selectively inhibiting the COX-2 enzyme, which reduces the production of prostaglandins responsible for pain and inflammation.
Serratiopeptidase helps break down abnormal proteins at the site of inflammation, reducing swelling and promoting faster tissue healing.

4. Benefits:
Rapid and sustained pain relief
Reduction in swelling and inflammation
Enhanced recovery in injury and post-surgical cases
Improved joint mobility and quality of life

5. Dosage & Administration: Take as prescribed by your physician, usually once or twice daily. Swallow the tablet whole with water; it may be taken with or without food. Do not crush or chew the tablet.

6. Common Side Effects:
Nausea, stomach pain, indigestion
Diarrhea or constipation
Swelling of hands or feet
Headache, dizziness, or skin rash

7. Precautions:
Not recommended for patients with severe liver or kidney impairment, active peptic ulcers, or known allergies to NSAIDs.
Use with caution in individuals with cardiovascular risk, and avoid during pregnancy or breastfeeding unless advised by a doctor.

📄 PRODUCT LIST
×